Zenas BioPharma (ZBIO) Other Operating Expenses (2025)
Zenas BioPharma's (ZBIO) quarterly Other Operating Expenses came in at $166.7 million in Q4 2025, up 3233.44% quarter-over-quarter from $5.0 million in Q3 2025.
Zenas BioPharma (ZBIO) Other Operating Expenses (2025) Analysis & Trends
Zenas BioPharma's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $166.7 million for Q4 2025.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $166.7 million in Q4 2025; TTM through Mar 2026 was $171.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $171.7 million, changed N/A from the prior year.
- Other Operating Expenses rose to $166.7 million in Q4 2025 per ZBIO's latest filing, from $5.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $166.7 million in Q4 2025 and bottomed at $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 166.67 Mn |
| Sep 30, 2025 | 5.00 Mn |